Generate a tailored SOP for Dr. Mark Connor. Improve your application with a focused, well-structured draft.
Mark Connor is a pharmacologist with expertise in psychoactive drugs, particularly cannabinoids, opioids, and psychedelics. His research focuses on how molecules interact with G protein-coupled receptors and ion channels to exert effects. Currently, he is investigating the pharmacology and toxicity of emerging synthetic cannabinoid receptor agonists, known as Spice or K2, and exploring the molecular mechanisms underlying the potential therapeutic actions of phytocannabinoids. His work also encompasses the pharmacology of novel psychedelics and the interactions with clinically used opioids and naturally occurring variants of opioid receptors.
Macquarie University • Sydney, Australia
Currently serving as a Professor and Associate Dean for Higher Degree Research.
Applied to Department of Business (MBA Program).